Altimmune, Inc. Common Stock ALT
i
Market datapartial · fetched 2026-11-06T20:46:15.807Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-06T20:46:13.023639299Z
FundamentalsAlpha Vantage · unavailable
Altimmune, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | ||||||
| 40Δ | ||||||
| 45Δ | ||||||
| 50Δ | 2.11 | 142.3% | 13.0% | |||
| 55Δ | 2.05 | 150.2% | 11.6% | 2.57 | 280.9% | 14.3% |
| 60Δ | 1.99 | 159.1% | 10.3% | 2.76 | 274.5% | 12.2% |
| 65Δ | 1.88 | 175.5% | 9.3% | 2.94 | 268.1% | 10.2% |
| 70Δ | 1.77 | 191.9% | 8.2% | 3.13 | 261.7% | 8.2% |
| 75Δ | 1.66 | 208.3% | 7.1% | 3.32 | 255.3% | 6.1% |
| 80Δ | 1.55 | 224.7% | 6.1% | 3.52 | 250.5% | 4.1% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- 2.11
- IV
- 142.3%
- B/E move
- 13.0%
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 2.05
- IV
- 150.2%
- B/E move
- 11.6%
- Pseudo strike
- 2.57
- IV
- 280.9%
- B/E move
- 14.3%
60Δ
- Pseudo strike
- 1.99
- IV
- 159.1%
- B/E move
- 10.3%
- Pseudo strike
- 2.76
- IV
- 274.5%
- B/E move
- 12.2%
65Δ
- Pseudo strike
- 1.88
- IV
- 175.5%
- B/E move
- 9.3%
- Pseudo strike
- 2.94
- IV
- 268.1%
- B/E move
- 10.2%
70Δ
- Pseudo strike
- 1.77
- IV
- 191.9%
- B/E move
- 8.2%
- Pseudo strike
- 3.13
- IV
- 261.7%
- B/E move
- 8.2%
75Δ
- Pseudo strike
- 1.66
- IV
- 208.3%
- B/E move
- 7.1%
- Pseudo strike
- 3.32
- IV
- 255.3%
- B/E move
- 6.1%
80Δ
- Pseudo strike
- 1.55
- IV
- 224.7%
- B/E move
- 6.1%
- Pseudo strike
- 3.52
- IV
- 250.5%
- B/E move
- 4.1%
Options history
Table
| Date | IV (%) |
|---|---|
| 277.95% | |
| 157.82% | |
| 136.80% | |
| 94.19% | |
| 338.01% | |
| 257.20% | |
| 366.04% | |
| 333.88% | |
| 259.06% | |
| 267.21% | |
| 435.56% | |
| 529.74% | |
| 328.23% | |
| 424.16% |
Biotechnology
ALXO
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. The company is headquartered in Burlingame,…
More →ANAB
AnaptysBio, Inc., a clinical-stage biotechnology company, is dedicated to developing therapeutic product candidates for inflammation and immuno-oncology indications. The company…
More →ANIX
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company is…
More →ANNX
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for autoimmune and neurodegenerative diseases. The company is headquartered in South…
More →ANRO
Description unavailable
More →ANTX
Anthem, Inc., is a health benefits company in the United States. The company is headquartered in Indianapolis, Indiana.
More →